Working… Menu
Trial record 1 of 2 for:    AB106
Previous Study | Return to List | Next Study

A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04395677
Recruitment Status : Recruiting
First Posted : May 20, 2020
Last Update Posted : February 3, 2021
Information provided by (Responsible Party):
AnHeart Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2022
Estimated Study Completion Date : December 31, 2025